Quality of life in CKD patients treated with erythropoiesis-stimulating agents

Editorial

Patrick S Parfrey et al. Am J Kidney Dis. 2010 Mar.

. 2010 Mar;55(3):423-5.

doi: 10.1053/j.ajkd.2009.12.014.

No abstract available

Comment on

Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review.
Gandra SR, Finkelstein FO, Bennett AV, Lewis EF, Brazg T, Martin ML. Gandra SR, et al. Am J Kidney Dis. 2010 Mar;55(3):519-34. doi: 10.1053/j.ajkd.2009.09.019. Epub 2009 Dec 23. Am J Kidney Dis. 2010. PMID: 20031287
Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents.
Johansen KL, Finkelstein FO, Revicki DA, Gitlin M, Evans C, Mayne TJ. Johansen KL, et al. Am J Kidney Dis. 2010 Mar;55(3):535-48. doi: 10.1053/j.ajkd.2009.12.018. Epub 2010 Feb 4. Am J Kidney Dis. 2010. PMID: 20133033